NCT02915497

Brief Summary

The objective of this study is to assess the feasibility and effectiveness of AEPET plus Resilience Based Therapy (RBT) versus RBT alone for the prevention of PTSD and depression in trauma patients. The intervention group who have AEPET plus RBT will have reduced level of post traumatic stress symptoms and depression post sessions as well as reduced symptoms of PTSD and depression at 4- 6 weeks as compared to the control group who have -"Resilience Based" less specific supportive therapy.

Trial Health

33
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Trial recruitment is currently suspended
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2016

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2016

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 14, 2016

Completed
3 months until next milestone

First Posted

Study publicly available on registry

September 27, 2016

Completed
6.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2023

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2025

Completed
Last Updated

December 5, 2024

Status Verified

December 1, 2024

Enrollment Period

7.5 years

First QC Date

July 14, 2016

Last Update Submit

December 3, 2024

Conditions

Keywords

Prolonged Exposure Therapy

Outcome Measures

Primary Outcomes (1)

  • PTSD Presence and Severity at 1 month follow-up

    Scale used to assess presence and measure severity: The Post-Traumatic Stress Disorder (PTSD) Symptom Scale -Interview (PSS-I)

    1 - 2 Months

Secondary Outcomes (4)

  • Change from Baseline Trauma-related Thoughts and Beliefs at Therapy Time-Point 2 and 1 month follow-up

    1 - 2 Months

  • Change from Baseline Depresssive Symptoms at Therapy Time-Point 2 and 1 month follow-up

    1 - 2 Months

  • PTSD Presence and Severity and Diagnosis at 1 month follow-up

    1 - 2 Months

  • Psychological Well-being at 1 month follow-up

    1 - 2 Months

Study Arms (2)

Treatment As Usual + Resilience-Based Supportive Therapy

NO INTERVENTION

Routine psychosocial management of trauma patients, including Manualized Resilience-Based Therapy.

Abbreviated Early Prolonged Exposure Therapy

EXPERIMENTAL

AEPET, including Manualized Resilience-Based supportive Therapy.

Behavioral: Abbreviated Early Prolonged Exposure Therapy

Interventions

Since many trauma patients are discharged within 4 weeks, AEPET with the same length (45 minutes - 1 hour) and number of sessions as PET, is given in a shorter time period (daily for 3 days as opposed to weekly over 3 weeks).

Abbreviated Early Prolonged Exposure Therapy

Eligibility Criteria

Age17 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Age 17-75
  • Experienced an acute physical trauma in the past 4 days where the patient believed it was potentially life-threatening in their mind at the time of the trauma
  • Have some clear memories of the trauma
  • Contain any risk factors for PTSD
  • An abbreviated Injury Severity (AIS) score of 1-3 (Minor, Moderate and Severe; not life threatening)

You may not qualify if:

  • Inability to communicate sufficiently in English to be able to complete questionnaires and provide informed consent
  • A diagnosis of psychosis, mental retardation or autism
  • Blood alcohol level of \>0.08mmol/L (25 mg/dl) at time of admission
  • Cognitive impairment apparent on interview/collateral from trauma team
  • Severe head injury
  • Withdrawal Criteria
  • If the patient is thought to be at risk to self or others, or be in need of immediate psychiatric assessment, in which case the patient will be referred urgently for assessment with psychosocial oncology or department of psychiatry
  • If the patient wishes to discontinue the study
  • If the patient is noted to be cognitively impaired during the course of the study such that he/she cannot complete a questionnaire reliably or physically impaired such that it is too burdensome for the patient to complete the questionnaire package.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sunnybrook Health Sciences Centre

Toronto, Ontario, M4N 3M5, Canada

Location

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Study Officials

  • Janet Ellis, MD

    Sunnybrook Health Sciences Centre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 14, 2016

First Posted

September 27, 2016

Study Start

February 1, 2016

Primary Completion

August 1, 2023

Study Completion

August 1, 2025

Last Updated

December 5, 2024

Record last verified: 2024-12

Locations